TheRAC.ca – Advocacy Journalism

Advocacy Journalism. The custom publishing hub of RandallAnthony Communications Inc.

Event celebrates diabetes advances, highlights work to be done

Lori BamberComment

By Lori Bamber, Managing Editor

In September, Danish-based pharmaceutical company Novo Nordisk collaborated with the Royal Danish Consulate General and the Canadian Diabetes Association to host Innovation in Diabetes Care: 90 Years and Beyond.

Held at the MaRS Discovery District, the event celebrated Novo Nordisk Canada’s 30-year anniversary and the significant contribution Canada has made to diabetes care.
Guests learned more about the findings of the Novo Nordisk-sponsored DAWN2 study, an international initiative that highlights new opportunities for improving active engagement, education and support of people with diabetes and their families.

 “The key to a better future for people living with diabetes is to foster these collaborations and, together, continue to drive innovation and education,” said Novo Nordisk president Vince Lamanna.


Highlights

The DAWN2™ study highlights new opportunities for improving active engagement, education and psychosocial support of people with diabetes and their families.

This global partnership initiative led by Novo Nordisk provides a new platform for dialogue and action to improve the lives of people with diabetes.


The ‘Rule of Halves’
• Of the estimated 382 million people with diabetes...
• about 50% are diagnosed...
• of whom about 50% receive care...
• of whom about 50% achieve treatment targets...
• of whom about 50% achieve desired outcomes.

Only 6% of people with diabetes live a life free
from diabetes-related complications


Click for full report SpecialFeature.diabetes.ca